Global Atherectomy Systems Market Size By Type (Directional Atherectomy, Orbital Atherectomy), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Atherectomy Systems Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.6 billion by 2031, growing at a CAGR of 9.1% during the forecast period of 2023–2031. This growth is fueled by the rising prevalence of peripheral artery disease (PAD), increasing adoption of minimally invasive procedures, and advancements in atherectomy technologies. Atherectomy systems are increasingly preferred for their effectiveness in removing arterial plaque with reduced procedural risks, driving their demand across hospitals and outpatient centers worldwide.

Drivers

1. Rising Prevalence of PAD and Cardiovascular Disorders:

An aging population and increasing rates of diabetes and obesity have contributed to the growing incidence of PAD, boosting the demand for atherectomy procedures.

2. Technological Advancements in Devices:

The market is witnessing rapid innovation with the launch of laser, orbital, and directional atherectomy systems offering enhanced precision and safety, encouraging wider clinical adoption.

3. Minimally Invasive Procedure Preference:

The global healthcare trend toward minimally invasive procedures due to their reduced recovery times and lower complication rates is significantly favoring the use of atherectomy systems.

Restraints

1. High Cost of Devices and Procedures:

The cost of atherectomy systems and associated consumables remains high, which may limit adoption in low-income healthcare settings and hinder market growth.

2. Risk of Procedural Complications:

Despite being minimally invasive, atherectomy procedures carry risks such as vessel perforation and distal embolization, which may restrict their use in certain patient populations.

Opportunity

1. Expanding Use in Outpatient and Ambulatory Settings:

The shift towards outpatient care and the increasing availability of mobile surgical suites create new avenues for atherectomy systems, particularly in cost-sensitive healthcare environments.

2. Growth Potential in Emerging Markets:

Healthcare infrastructure improvements and growing awareness of PAD in Asia-Pacific, Latin America, and parts of the Middle East present substantial opportunities for market expansion.

Market by System Type Insights

In 2023, the Directional Atherectomy Systems segment held the largest market share due to its clinical efficacy in targeted plaque removal. However, Rotational Atherectomy Systems are anticipated to exhibit the fastest growth during the forecast period, driven by their widespread use in treating heavily calcified lesions and the development of compact, user-friendly designs.

Market by End-use Insights

The Hospitals Segment dominated the market in 2023, accounting for over 60% of total revenue. Hospitals continue to lead in procedural volume due to their comprehensive facilities and specialist availability. Meanwhile, Ambulatory Surgical Centers (ASCs) are expected to experience rapid growth owing to their cost-efficiency and increasing integration of advanced vascular devices.

Market by Regional Insights

North America held the largest share in the global atherectomy systems market in 2023, supported by a robust healthcare infrastructure, favorable reimbursement scenarios, and high patient awareness. Asia-Pacific is projected to witness the highest growth rate through 2031, propelled by rising healthcare expenditures, growing cases of PAD, and increased access to advanced vascular therapies in countries such as China, India, and Japan.

Competitive Scenario

Key players in the Global Atherectomy Systems Market include Boston Scientific Corporation, Cardiovascular Systems, Inc., Medtronic plc, Avinger Inc., Koninklijke Philips N.V., BD (Becton, Dickinson and Company), Ra Medical Systems, and Abbott Laboratories. These companies are focused on product innovation, clinical trials, regulatory approvals, and strategic acquisitions to enhance their market presence.

Key Market Developments:

In 2023, Boston Scientific received FDA clearance for its next-gen laser atherectomy catheter featuring improved plaque ablation capability.

Cardiovascular Systems, Inc. expanded its product portfolio in 2024 with an orbital atherectomy device specifically designed for peripheral interventions.

In 2025, Philips launched a hybrid imaging-guided atherectomy system to improve procedural outcomes through real-time visualization.

Scope of Work – Global Atherectomy Systems Market

Report Metric Details

Market Size (2023) USD 1.3 Billion

Projected Market Size (2031) USD 2.6 Billion

CAGR (2023–2031) 9.1%

Market Segments By System Type (Directional, Rotational, Orbital, Laser), By End-use (Hospitals, ASCs, Others)

Growth Drivers Increasing PAD cases, Minimally invasive surgery trends, Technological innovation

Opportunities Emerging markets expansion, Growth in outpatient procedures

FAQs

1) What is the current market size of the Global Atherectomy Systems Market?

The Global Atherectomy Systems Market was valued at USD 1.3 billion in 2023.

2) What is the major growth driver of the Global Atherectomy Systems Market?

The primary growth driver is the increasing prevalence of peripheral artery disease and the rising preference for minimally invasive procedures.

3) Which is the largest region during the forecast period in the Global Atherectomy Systems Market?

North America is expected to maintain its dominance during the forecast period due to its advanced healthcare infrastructure and high adoption rate.

4) Which segment accounted for the largest market share in the Global Atherectomy Systems Market?

The Directional Atherectomy Systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Atherectomy Systems Market?

Key players include Boston Scientific, Medtronic, Cardiovascular Systems, Avinger, and Philips.